Sharpening the edge for precision cancer immunotherapy: Targeting tumor antigens through oncolytic vaccines

Namit Holay; Youra Kim; Patrick Lee; Shashi Gujar

doi:10.3389/fimmu.2017.00800

Sharpening the edge for precision cancer immunotherapy: Targeting tumor antigens through oncolytic vaccines

Namit Holay, Youra Kim, Patrick Lee, Shashi Gujar

Economics, Econometrics and Finance

科研成果: 期刊稿件 › 短篇评述 › 同行评审

15 引用（Scopus）

源语言	英语
文章编号	800
期刊	Frontiers in Immunology
卷	8
期	JUL
DOI	https://doi.org/10.3389/fimmu.2017.00800
出版状态	已出版 - 7月 13 2017

!!!ASJC Scopus Subject Areas

免疫学和过敏症
免疫学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.3389/fimmu.2017.00800

其它文件与链接

引用此

@article{b88c52e815e14a01b1e41aa1efc2b334,

title = "Sharpening the edge for precision cancer immunotherapy: Targeting tumor antigens through oncolytic vaccines",

keywords = "Antitumor immunity, Cancer immunotherapy, Oncolytic vaccines, T cells, Tumor antigens, Tumor major histocompatibility complex ligandome",

author = "Namit Holay and Youra Kim and Patrick Lee and Shashi Gujar",

note = "Publisher Copyright: {\textcopyright} 2017 Holay, Kim, Lee and Gujar.",

year = "2017",

month = jul,

day = "13",

doi = "10.3389/fimmu.2017.00800",

language = "English",

volume = "8",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S. A.",

number = "JUL",

}

TY - JOUR

T1 - Sharpening the edge for precision cancer immunotherapy

T2 - Targeting tumor antigens through oncolytic vaccines

AU - Holay, Namit

AU - Kim, Youra

AU - Lee, Patrick

AU - Gujar, Shashi

PY - 2017/7/13

Y1 - 2017/7/13

KW - Antitumor immunity

KW - Cancer immunotherapy

KW - Oncolytic vaccines

KW - T cells

KW - Tumor antigens

KW - Tumor major histocompatibility complex ligandome

UR - http://www.scopus.com/inward/record.url?scp=85023171326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023171326&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2017.00800

DO - 10.3389/fimmu.2017.00800

M3 - Short survey

AN - SCOPUS:85023171326

SN - 1664-3224

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

IS - JUL

M1 - 800

ER -

Sharpening the edge for precision cancer immunotherapy: Targeting tumor antigens through oncolytic vaccines

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此